Greetings on yet another edition of The Prescription!
With the steep rise in Hospital acquired infections (HAI) in the country, BD-India, a leading medical technology company organised 'Heal-o-nomics’. The program is conceptualized to apprehend the challenge of preventing HAIs with the aim to achieve better health outcomes at optimised cost. Read more on this and why scientists are upset by the AYUSH Ministry advisory under Pharma Injections.
New rules to treat cancer patients, barring non medicos to sign reports, setting up of new vertical to check garage manufacturing, fixing retail prices of 22 formulations make up this fortnight’s Drug Laws And Policy Injections while go through an interesting read under PSM India Capsules section on how excipients in medications are triggering adverse reactions in some patients and a device to test antibiotic resistance developed by a Chennai team.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
“Under the Pharmaco vigilance programme of India, the CDSCO collects adverse drug reactions reported from across 250 adverse drug reactions monitoring centres, majority of these are located in various medical colleges. Due to a large patient pool, the CDSCO is able to generate robust and quality data which is further analysed for signals.”
S. Eswara Reddy,
Drugs Controller General of India,
Union Ministry of Health and Family Welfare
An oral drug product contains both the active pharmaceutical ingredient (API) as well as a mixture of inactive ingredients, or excipients. Inactive ingredients are used to alter the physical properties of a medication, while the API is intended to produce the desired pharmaceutical effect of the agent. Excipients may be added to a medication to improve absorption, alter taste, increase stability, or render the medication tamper resistant.
Trump Says He Will Allow US States To Buy Cheaper Medicines From Abroad
WASHINGTON, 9 MAY 2019: The Trump administration is working to allow U.S. states to buy prescription drugs from other countries if the medications cost less, President Donald Trump said on Thursday.
US FDA Approves First Vaccine For Dengue, But Limits Its Use
Maryland, 5 May 2019: The US Food and Drug Administration has approved the first vaccine for dengue, Dengvaxia, but placed significant restrictions on its use because the vaccine has been shown to put some people at heightened risk for a severe form of the disease.
Mexican Official Resigns As HIV Drug Shortage Sparks Outcry
MEXICO CITY, 10 MAY 2019: A top Mexican health official said on Thursday that he had resigned amid growing anger over drug shortages that have left hundreds of HIV patients without life-saving medicines.
New US FDA Website Launched
Monday would be the official launch date, but you will begin to see the new site beginning this weekend as we bring it online in phases. We expect the new site to be fully live on Monday, April 29,” an agency spokesperson told Focus via email.
Partnership For Safe Medicines’ Statement In Response To President Trump’s Comments On Foreign Drug Importation
Washington, D.C. (May 9, 2019): Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement in response to President Trump’s comments on drug importation: “We have worked on this issue for more than 15 years and it is simply not possible to import medicines safely from a foreign country’s drug supply. The existing safety provided to American patients is second to none, but we are facing an unprecedented and global counterfeit medicine crisis. In over half of our states, there have been deaths from counterfeit drugs made with fentanyl. Just last year, a licensed Canadian wholesaler pleaded guilty to sending counterfeit cancer medication to American doctors.
Deadly Fentanyl-Laced Counterfeit Pills Have Spread To 46 States In The Last Two And A Half Years
February 20, 2019: When, in October 2016, The Partnership for Safe Medicines began tracking the incidence of counterfeit prescription pills made with fentanyl and fentanyl analogues, we were startled to find that the pills had been found in 25 states, and had been linked to deaths in 17 of them.
Frequently Asked Questions
Q1. Fatty Liver: What It Is, and How to Get Rid of It ?
Ans: Fatty liver disease is becoming increasingly common in many parts of the world, affecting about 25% of people globally. It is linked to obesity, type 2 diabetes and other disorders characterized by insulin resistance. What's more, if fatty liver isn't addressed, it may progress to more serious liver disease and other health problems. Read More>>>
Zinc Oxide Can Prevent Fatty Liver Disease, Finds IIT Mandi Team
Article contributed by Ms. Meghna Mehta, Mumbai
A research team from IIT Mandi has shown that zinc oxide can prevent fatty liver disease by blocking accumulation of fat in the liver. The research team led by Dr. Prosenjit Mondal, Assistant Professor, School of Basic Sciences, Indian Institute of Technology Mandi, and Dr. Debabrata Ghosh from CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow has shown that zinc oxide can be very useful in preventing Non-Alcoholic Fatty Liver Disease (NAFLD). Their work has recently been published in the journal, Nanomedicine: Nanotechnology, Biology and Medicine.
Avinash Raut, Pharma professionalThe PSM-India’s initiated “The Prescription” newsletter provides beneficial information and a very positive endeavour.
Dr. Gargi Dixit, Physician: India continues to be among those countries of the world that have a high burden of diseases. Thanks PSM India for updated news on such crucial matters!
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.